Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA methyltransferases, DNA methyltransferase (Dnmt)3a and Dnmt3b (Dnmt3s). Glutathione-S-transferase pulldown assay revealed that PU.1 directly interacted with the ATRX domain of Dnmt3s through the ETS domain. Dnmt3s repressed the transcriptional activity of PU.1 on a reporter construct with trimerized PU.1-binding sites. The repression was recovered by addition of 5-aza-deoxycitidine, a DNA methyltransferase inhibitor, but not trichostatin A, a histone deacetylase inhibitor. Bisulfite sequence analysis revealed that several CpG sites in the promoter region neighboring the PU.1-binding sites were methylated when Dnmt3s were coexpressed with PU.1. We also showed that the CpG sites in the p16(INK4A) promoter were methylated by overexpression of PU.1 in NIH3T3 cells, accompanied by a downregulation of p16(INK4A) gene expression. These results suggest that PU.1 may downregulate its target genes through an epigenetic modification such as DNA methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“previous studies have shown that PU.1 can form a complex with DNMT3a and DNMT3b [46].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [46]
Citations
Cites
1 retracted
Majumder, S., Ghoshal, K., Datta, J., Bai, S., Dong, X., Quan, N., Plass, C., & Jacob, S. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111662200 · Cited by 52 · cited 1×
“There is growing evidence to suggest that Dnmt1 interacts with the methylated DNAbinding protein (MBD) family (Tatematsu et al., 2000) and that Dnmt3s mediate the binding of MBD family members such as MeCP2 to methylated CpG sites (Majumder et al., 2002).”
BackgroundRetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“Histone deacetylase removes the acetyl groups from the amino-terminal of the histone tails, which triggers the assembly of a tightly packed chromatin inaccessible to the transcriptional machinery (Jenuwein and Allis, 2001).”
BackgroundMethylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646 · cited 1×
“The method of bisulfite treatment has been explained previously (Herman et al., 1996).”
MethodMethylation-Induced Repression— Belts, Braces, and Chromatin
Bird, A. P., & Wolffe, A. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81532-9 · Cited by 1,827
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,651 · cited 2×
“Recent observations convinced us that the two major epigenetic gene-silencing mechanisms, the acetylation of histones and the methylation of DNA, are linked to Oncogene each other (Okano et al., 1998).”
BackgroundDNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052 · cited 1×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundThe macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954 · cited 1×
“PU.1 was identified as the gene encoding the protein that binds to a purine-rich sequence (PU box) in the promoter region of the mouse major histocompatibility complex (MHC) class II I-Ab gene (Klemsz et al., 1990).”
BackgroundRobertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942 · cited 2×
“All of them have been shown to interact directly with the mSin3A–HDACs complex (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 2001; Datta et al., 2003).”
BackgroundCloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells
Bestor, T., Laudano, A., Mattaliano, R., & Ingram, V. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90122-2 · Cited by 913 · cited 1×
“There are at least three different major catalytically active Dnmts, Dnmt1 (Bestor et al., 1988), Dnmt3a and Dnmt3b (Okano et al., 1998), which are involved in cellular DNA methylation.”
BackgroundDi Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Coco, F. L., Kouzarides, T., Nervi, C., et al. (2002) · Science · doi:10.1126/science.1065173 · Cited by 787 · cited 1×
“The report that a complex of the PML–RAR fusion protein and Dnmts contributes to hypermethylation of the RARb2 promoter to silence the gene expression is the first example of site-specific DNA methylation (Croce et al., 2002).”
Background
Cited by
Items 101–133 of 133
Breaking the Silence: The Interplay Between Transcription Factors and DNA Methylation
Baron, B. (2012) · InTech eBooks · doi:10.5772/55021 · Cited by 11
“[135] Suzuki M, Yamada T, Kihara-Negishi F, Sakurai T, Hara E, Tenen DG, Hozumi N, Oikawa T.”
BackgroundHe, C., Wang, Z.-Y., Tian, K., Liu, W., Li, Y.-B., Yan, H., Yu, L., Pang, W., Jiang, Y., & Liu, Y. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1312090 · Cited by 7
Manríquez, R. A., Sandoval, M., Loncoman, C., Tafalla, C., Avendaño-Herrera, R. E., & Cárcamo, J. G. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108947 · Cited by 8
Epigenetic aberrations in myeloid malignancies (Review)
Takahashi, S. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1417 · Cited by 7
The Role of DNMT3B Mutations in the Pathogenesis of ICF Syndrome
Gatto, S., D’Esposito, M., & Matarazzo, M. R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3345-3_2 · Cited by 6
Xu, L., Xi, G., Jun-yan, Y., Jiang, R., Jiang, X., Chen, G. G., & Liu, Z. (2021) · The FASEB Journal · doi:10.1096/fj.202001467r · Cited by 6
Samuel, M. S., Samuel, M. S., Lundgren–May, T., & Ernst, M. (2007) · Growth Factors · doi:10.1080/08977190801931081 · Cited by 6
ATRX ADD domain is a versatile module for recognizing macroH2A, H3, and beyond
Yan, S., Wang, X., Ge, K., Wang, D., & Chen, Y. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025085 · Cited by 5
“DNMT3A ADD exhibits broad interaction capabilities with multiple protein partners such as SUV39H1 [42], SETDB1 [43], EZH2 [44], MECP2 [45], HP1 β [42], Myc [46], PU.1 [47], and RP58 [48].”
Methylation and myelodysplastic syndromes: When and where?
Quesnel, B. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.05.004 · Cited by 4
Besson, J.-M., Etcheverry, A., Nadaradjane, A., Bougras-Cartron, G., Aubry, M., Frenel, J., Chevanieu, A., Lopez, M., Mosser, J., & Cartron, P. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01943-8 · Cited by 5
Cancer RNome: Evolution and Sustenance
Arora, M., & Kaul, D. (2018) · Springer eBooks · doi:10.1007/978-981-13-1568-8_3 · Cited by 4
PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
Takahashi, S. (2011) · InTech eBooks · doi:10.5772/25853 · Cited by 3
“1 and DNA methyltransferase (Dnmt) 3a and Dnmt3b via the Ets domain (Suzuki et al., 2006).”
BackgroundMethodInfluentialCA10 is associated with HBV-related hepatocarcinogenesis
Chung, K., Chen, Y., Hong, C., Chang, I., Lin, S., Liang, L., Chen, Y., Yeh, C., & Huang, S.-F. K. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101303 · Cited by 5
Methyltransferases in myelodysplastic syndromes: Guilty or not guilty?
Quesnel, B. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.11.004 · Cited by 2
Developmental regulation of DNA methyltransferases
Lees‐Murdock, D. J., & Walsh, C. P. (2005) · Wiley eBooks · doi:10.1002/047001153x.g103228 · Cited by 2
Chen, F., Xu, Z., Bai, X., He, Y., Zhou, R., Bai, X., & Zhu, Y. (2026) · The FASEB Journal · doi:10.1096/fj.202502730rr · Cited by 3
Mouse Models to Study DNA Methylation in Cancer Research
Savelyeva, I. V., & Rosenbauer, F. (2013) · Springer eBooks · doi:10.1007/978-3-642-38404-2_2 · Cited by 1
Yang, S., Guo, C., Zhang, Y., Sun, J., & Hong, X. (2015) · Experimental and Applied Acarology · doi:10.1007/s10493-015-9957-5 · Cited by 1
“1B1), which contains two C4-type zinc fingers to mediate various protein–protein interactions (Suzuki et al. 2006; Fuks et al. 2001; Otani et al. 2009).”
BackgroundEpigenetics and the evolution and feralization of domestic animals
Jensen, P., & Wright, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19051-3.00008-5 · Cited by 1
Wickrema, A., Verma, A. K., Godley, L. A., Skoultchi, A., Greally, J. M., Gligich, O., Suzuki, M., Steidl, U. G., Bathon, K., Maqbool, S. B., et al. (2013)
Self-citationCancer-Linked DNA Hypermethylation and Hypomethylation: Chromosome Position Effects
Ehrlich, M. (2008) · CRC Press eBooks · doi:10.1201/9781420045802.ch13
Global DNA Demethylation During Erythropoiesis: A Dissertation
Shearstone, J. R. (2011) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hs36-k802
Introductory Chapter: Gene Expression in Eukaryotic Cells
Uchiumi, F. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103152
Parameters that determine the direction of transcription
Uchiumi, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818787-6.00009-6
Toward Understanding Pharmacological Modulation of DNA Methylation
Horton, J. R. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-00193
Drug Discovery for Chromatin Readers, Writers, Erasers, Remodelers and Epitranscriptomic Targets
(2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-part3
Antagonistic effects of PU.1 on Gfi-1B-induced erythroid colony formation in human cord blood cells
Manabe, N., Sakurai, T., Kihara‐Negishi, F., Nakazawa, Y., Yamada, T., Iwama, A., & Oikawa, T. (2025) · Cellular and Molecular Biology · doi:10.14715/cmb/2025.71.3.6
“Our previous findings demonstrated that PU.1 can interact with HDAC1, MeCP2, and Dmnt3s [24-26], and Gfi-1B has a SNAG repression domain at the N-terminal region for binding co-repressors [19].”
Self-citationDNA Methyltransferases in Human Biology and Diseases: Epigenetic Regulator to Therapeutic Targets
Arya, A. K., Singh, P., & Sharma, V. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-5071-5_11 · Cited by 1
Méthylation de l'ADN : fonctions et ciblage au cours du développement chez la souris
Dahlet, T. (2019) · theses.fr (ABES) · doi:10.70675/9ac7845czeb7dz4b51z9102zfa7c1da173ca
Roos‐Weil, D. (2018) · theses.fr (ABES) · doi:10.70675/1030cb13z12b8z4f7cz8f8az165206a6209a
Développement de stratégies innovantes pour cibler la méthylation de l’ADN dans les cancers
Serhouni, A. (2021) · theses.fr (ABES) · doi:10.70675/1f974c7cz0d1dz4afezbbdcz8577cc5f65bd
A framework for genome-wide characterization of DNA methylation and variant effect prediction
Mao, W., Chen, K., Park, C. Y., Theesfeld, C. L., & Troyanskaya, O. G. (2026) · Nature Genetics · doi:10.1038/s41588-026-02807-4
Metadata
- Authors
- Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., Hara, E., Tenen, D. G., Hozumi, N., & Oikawa, T.
- Affiliations
- Sasaki Institute (JP)
- Tokushima University (JP)
- Harvard University (US)
- Tokyo University of Science (JP)
- Corresponding author
- Oikawa, T
- Venue
- Oncogene
- Published
- 2005-12-05
- Volume
- 25
- Issue
- 17
- Pages
- 2477-2488
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1984410404
- Cited by
- 132
- References
- 43
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 1 · 2022: 10 · 2021: 6 · 2020: 9 · 2019: 8 · 2018: 4 · 2017: 2 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 4
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- PU.1, DNMT3A, DNMT3B, DNA methylation, transcriptional repression, ETS transcription factors, CpG methylation, p16INK4a, epigenetic regulation, hematopoietic transcription factors, decitabine
- MeSH terms
- Decitabine, DNA Methyltransferase 3A, DNA Methyltransferase 3B, Proto-Oncogene Protein Spi-1, Animals, Azacitidine, DNA (Cytosine-5-)-Methyltransferases, Histone Deacetylases, Hydroxamic Acids, Promoter Regions, Genetic, Proto-Oncogene Proteins, Transcription, Genetic, Trans-Activators, DNA Methylation, Cyclin-Dependent Kinase Inhibitor p16, NIH 3T3 Cells, Chromatin Immunoprecipitation, Immunoprecipitation, Mice, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.